| Ident. | Authors (with country if any) | Title |
|---|
| 000015 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19 |
| 000016 (2020) |
B. Coutard [France] ; C. Valle [France] ; X. De Lamballerie [France] ; B. Canard [France] ; N. G. Seidah [Canada] ; E. Decroly [France] | The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade |
| 000021 (2020) |
Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. |
| 000034 (2020) |
Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [France] ; Geir Bj Rklund [Norvège] | Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic |
| 000038 (2020) |
G. Solé [France] ; E. Salort-Campana [France] ; Y. Pereon [France] ; T. Stojkovic [France] ; K. Wahbi [France] ; P. Cintas [France] ; D. Adams [France] ; P. Laforet [France] ; V. Tiffreau [France] ; I. Desguerre [France] ; Li Pisella [France] ; A. Molon [France] ; S. Attarian [France] | Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network |
| 000076 (2018) |
Phanramphoei N. Frantz [France, Thaïlande] ; Samaporn Teeravechyan [Thaïlande] ; Frédéric Tangy [France] | Measles-derived vaccines to prevent emerging viral diseases |
| 000078 (2018) |
Mathieu Bourgarel [France] ; Davies M. Pfukenyi [Zimbabwe] ; Vanina Boué [France] ; Loïc Talignani [France] ; Ngoni Chiweshe [Zimbabwe] ; Fodé Diop [France] ; Alexandre Caron [Mozambique] ; Gift Matope [Zimbabwe] ; Dorothée Missé [France] ; Florian Liégeois [France] | Circulation of Alphacoronavirus, Betacoronavirus and Paramyxovirus in Hipposideros bat species in Zimbabwe. |
| 000082 (2017-12-13) |
Marc Bouchoucha [France] | Potential use of ports as alternative nursery habitats by coastal marine fishes : Insights from Diplodus species in the Northwestern Mediterranean |
| 000084 (2017-07-01) |
Dimitrii Tanese [France] ; Ju-Yun Weng [France] ; Valeria Zampini [France] ; Vincent De Sars [France] ; Marco Canepari [France] ; Balazs Rozsa ; Valentina Emiliani [France] ; Dejan Zecevic [États-Unis] | Imaging membrane potential changes from dendritic spines using computer-generated holography |
| 000092 (2017) |
Elodie Monchatre-Leroy ; Franck Boué ; Jean-Marc Boucher ; Camille Renault ; François Moutou ; Meriadeg Ar Gouilh [France] ; Gérald Umhang | Identification of Alpha and Beta Coronavirus in Wildlife Species in France: Bats, Rodents, Rabbits, and Hedgehogs |
| 000110 (2016) |
Nathalie Kin [France] ; Astrid Vabret [France] | [New therapies against HCV]. |
| 000128 (2015) |
F. Rodhain [France] | Bats and Viruses: complex relationships |
| 000142 (2014) |
Mathieu Métifiot [France] ; Samir Amrane [France] ; Simon Litvak [France] ; Marie-Line Andreola [France] | G-quadruplexes in viruses: function and potential therapeutic applications |
| 000148 (2014) |
Jaffar A. Al-Tawfiq [Arabie saoudite, États-Unis] ; Alimuddin Zumla [Royaume-Uni, Arabie saoudite] ; Philippe Gautret [France] ; Gregory C. Gray [États-Unis] ; David S. Hui [Hong Kong] ; Abdullah A. Al-Rabeeah [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite] | Emerging respiratory tract infections 1: Surveillance for emerging respiratory viruses |
| 000161 (2013) |
Everett Clinton Smith [États-Unis] ; Hervé Blanc [France] ; Marco Vignuzzi [France] ; Mark R. Denison [États-Unis] | Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics |
| 000164 (2013) |
Romulus Breban [France] ; Julien Riou [France] ; Arnaud Fontanet [France] | Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk |
| 000176 (2012) |
Paul Coulerie [France] ; Cécilia Eydoux ; Edouard Hnawia ; Laetitia Stuhl ; Alexandre Maciuk ; Nicolas Lebouvier ; Bruno Canard ; Bruno Figadère ; Jean-Claude Guillemot ; Mohammed Nour | Biflavonoids of Dacrydium balansae with potent inhibitory activity on dengue 2 NS5 polymerase. |
| 000186 (2012) |
Paul Coulerie [France] ; Cécilia Eydoux [France] ; Edouard Hnawia [France] ; Laetttia Stuhl [France] ; Alexandre Maciuk [France] ; Nicolas Lebouvier [France] ; Bruno Canard [France] ; Bruno Figadere [France] ; Jean-Claude Guillemot [France] ; Mohammed Nour [France] | Biflavonoids of Dacrydium balansae with Potent Inhibitory Activity on Dengue 2 NS5 Polymerase |
| 000197 (2011) |
E. D Lessandro [France] ; G. Soula [France] ; Y. Jaffré [France] ; B. Gourouza [Niger] ; E. Adehossi [Niger] ; J. Delmont [France] | Pandémie grippale A/H5N1 et niveau de préparation du Niger: une étude sur les connaissances des soignants et l’organisation générale des soins |
| 000209 (2011) |
Martial Jaume [Hong Kong] ; Ming S. Yip [Hong Kong] ; Chung Y. Cheung [Hong Kong] ; Hiu L. Leung [Hong Kong] ; Ping H. Li [Hong Kong] ; Francois Kien [Hong Kong] ; Isabelle Dutry [Hong Kong] ; Benoit Callendret [France] ; Nicolas Escriou [France] ; Ralf Altmeyer [Hong Kong] ; Beatrice Nal [Hong Kong] ; Marc Daëron [France] ; Roberto Bruzzone [Hong Kong, France] ; J. S. Malik Peiris [Hong Kong] | Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway |
| 000221 (2010) |
I. Martin-Loeches [Espagne] ; T. Lisboa [Espagne, Brésil] ; A. Rhodes [Royaume-Uni] ; R. P. Moreno [Portugal] ; E. Silva [Brésil] ; C. Sprung [Israël] ; J. D. Chiche [France] ; D. Barahona [Équateur] ; M. Villabon [Colombie] ; C. Balasini [Argentine] ; R. M. Pearse [Royaume-Uni] ; R. Matos [Portugal] ; J. Rello [Espagne, Canada] | Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection |
